Associated Papers
KRAS signaling in malignant pleural mesothelioma.
Marazioti A et al.
Embo Molecular Medicine, 2022
34898002 (PubMed )
Supplement: EMMM-14-e13631-s002.xlsx › Source_Data_-_Fig_3H_part_A
A Tumor-Specific Neo-Antigen Caused by a Frameshift Mutation in BAP1 Is a Potential Personalized Biomarker in Malignant Peritoneal Mesothelioma.
Lai J et al.
International Journal of Molecular Sciences, 2016
Computational analysis of the mutations in BAP1, PBRM1 and SETD2 genes reveals the impaired molecular processes in renal cell carcinoma.
Piva F et al.
Oncotarget, 2015
26452128 (PubMed )
Supplement: oncotarget-06-32161-s002.xls › Predictions
Select a paper to view details